Lineage Cell Therapeutics Inc宣布与William Demant Invest合作开发用于听力损失治疗的Resonance™ (Anp1)

美股速递
Aug 26, 2025

Lineage Cell Therapeutics Inc宣布与William Demant Invest达成研究合作协议,共同开发用于治疗听力损失的Resonance™ (Anp1)产品。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10